E-MAIL   PASSWORD Forgot password?New user?

ADHD


Actavis Receives FDA Approval Of Atomoxetine HCl Capsules
Thu, 02 Sep 2010 02:00:00 PDT


Alzheimer's / Dementia


Eisai Announces The Start Of The First Clinical Study Of Ban2401, A Novel Monoclonal Antibody Targeting Neurotoxic Protofibrils
Thu, 02 Sep 2010 04:00:00 PDT


Bio-terrorism / Terrorism


Soligenix Announces Publication Of Article Identifying Domains Within The Ricin Toxin A Subunit As Targets Of Protective Antibodies
Fri, 03 Sep 2010 02:00:00 PDT


Breast Cancer


Roche Provides Update On FDA Application For T-DM1
Thu, 02 Sep 2010 03:00:00 PDT


Cancer / Oncology


Nanobiotechnology To Fight Cancer And Other Illnesses
Thu, 02 Sep 2010 00:00:00 PDT


Celsion Receives SBIR Grant To Expand Its Technology Platform
Fri, 03 Sep 2010 05:00:00 PDT


Diabetes


Halozyme Begins Phase 2 Clinical Trials With Insulin Analogs Lispro And Aspart With RHuPH20 In Type 1 And Type 2 Diabetes
Fri, 03 Sep 2010 02:00:00 PDT


Eye Health / Blindness


Proprietary Zinc/Phytase Formulation Improved Botulinum Toxin A Results
Thu, 02 Sep 2010 02:00:00 PDT


ReVision's Fenretinide (RT-101) Reduced Incidence Of Choroidal Neovascularization By More Than 50 Percent In Patients With Geographic Atrophy
Thu, 02 Sep 2010 02:00:00 PDT


Microplasmin Meets Primary Endpoint In Second Phase III Trial In VMA, Confirms Positive Findings Of First Trial
Thu, 02 Sep 2010 02:00:00 PDT


Heart Disease


BRINAVESS™ (vernakalant) For Infusion Approved In The European Union For Rapid Conversion Of Recent Onset Atrial Fibrillation
Thu, 02 Sep 2010 04:00:00 PDT


Infectious Diseases / Bacteria / Viruses


Optimer Pharmaceuticals Announces Presentations Of Additional Fidaxomicin Phase 3 Data At Upcoming ICAAC Annual Meeting
Fri, 03 Sep 2010 04:00:00 PDT


Litigation / Medical Malpractice


Botox Maker Allergan Agrees To Pay $600 Million And Pleads Guilty To Misdemeanor
Wed, 01 Sep 2010 11:00:00 PDT


Lymphoma / Leukemia / Myeloma


Novartis Drug Tasigna® Approved In Switzerland After Fast-track Review For Treatment Of Patients With Newly Diagnosed Ph+ CML
Thu, 02 Sep 2010 03:00:00 PDT


Obesity / Weight Loss / Fitness


Orexigen Partners With Takeda To Commercialize Obesity Drug Contrave (Naltrexone SR/Bupropion SR)
Thu, 02 Sep 2010 09:00:00 PDT


Pain / Anesthetics


QRxPharma Announces Interim Analysis Of Final Pivotal Phase 3 Study For MoxDuo®IR
Thu, 02 Sep 2010 02:00:00 PDT


Transdel Pharmaceuticals Presents Phase 3 Study Data On Ketotransdel® At World Pain Congress In Montreal, Canada
Fri, 03 Sep 2010 02:00:00 PDT


Pharma Industry / Biotech Industry


Therapeutic Workshops To Highlight Opportunities In Biotech At 9th Annual BIO Investor Forum
Thu, 02 Sep 2010 06:00:00 PDT


Cetero Research Launches Seminar Series On Accelerated Proof-of-Concept In Drug Development
Fri, 03 Sep 2010 04:00:00 PDT


Allergan Resolves United States Government Investigation Of Past Sales And Marketing Practices Relating To Certain Therapeutic Uses Of BOTOX(R)
Fri, 03 Sep 2010 02:00:00 PDT


Regulatory Affairs / Drug Approvals


Egg Recall, Drug Approval Time Raise Questions About FDA Resources
Fri, 03 Sep 2010 05:00:00 PDT


Stem Cell Research


New Research Demonstrates Safety Of Cord-blood-derived Stem Cell Treatments
Fri, 03 Sep 2010 03:00:00 PDT


Tropical Diseases


Technique That Could Resolve The Problem Of Fake Medicines In Developing Countries
Fri, 03 Sep 2010 01:00:00 PDT


Urology / Nephrology


Agensys, An Affiliate Of Astellas, Announces Initiation Of Phase I Clinical Trial Of AGS-16M8F For Renal Cancer
Thu, 02 Sep 2010 02:00:00 PDT


Women's Health / Gynecology


Also In Global Health News: Congo Security Warnings; Niger Food Crisis; Drug Cost In Developing Countries; Measles Vaccination In China
Fri, 03 Sep 2010 06:00:00 PDT